$TOCA Tocagen and Forte Biosciences Announce Merger

Focused on Advancing Forte's Late-Stage Clinical Program for Atopic Dermatitis

$14 Million to be Invested by Alger, BVF Partners LP and OrbiMed Prior to the Closing of the Transaction.